Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Sudowe, Stephan ^a   Dominitzki, Sabine ^a   Montermann, Evelyn ^a   Bros, Matthias ^a   Grabbe, Stephan ^a   Reske Kunz, Angelika B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Dendritic cells; Fascin promoter; Gene gun mediated DNA vaccination; Keratin 5 promoter; Keratinocytes; Type I allergy

Indexed keywords

BETA GALACTOSIDASE; CYTOKERATIN 5; DNA VACCINE; FASCIN; GAMMA INTERFERON; IMMUNOGLOBULIN E;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BIOLISTIC TRANSFORMATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA IMMUNIZATION; GENE GUN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN PRODUCTION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TH1 CELL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; BETA-GALACTOSIDASE; BIOLISTICS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENETIC VECTORS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; KERATIN-5; KERATINOCYTES; LANGERHANS CELLS; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VACCINES, DNA;

EID: 68249160778     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02947.x     Document Type: Article

References (62)

1. Chen D, Maa YF, Haynes JR. Needle-free epidermal powder immunization. Expert Rev Vaccines 2002 1 : 265 76.
2. Fuller DH, Loudon P, Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 2006 40 : 86 97.
3. Ulmer JB, Wahren B, Liu MA. Gene-based vaccines: recent technical and clinical advances. Trends Mol Med 2006 12 : 216 22.
4. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996 2 : 1122 8.
5. + T cells after gene gun immunization. J Exp Med 1998 188 : 1075 82.
6. Bouloc A, Walker P, Grivel JC, Vogel JC, Katz SI. Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells. Eur J Immunol 1999 29 : 446 54.
7. Bot A, Stan AC, Inaba K, Steinman R, Bona C. Dendritic cells at a DNA vaccination site express the encoded influenza nucleoprotein and prime MHC class I-restricted cytolytic lymphocytes upon adoptive transfer. Int Immunol 2000 12 : 825 32.
8. Chen D, Payne LG. Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res 2002 12 : 97 104.
9. Garg S, Oran A, Wajchman J, Sasaki S, Maris CH, Kapp JA, Jacob J. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 2003 4 : 907 12.
10. Stoecklinger A, Grieshuber I, Scheiblhofer S et al. Epidermal Langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol 2007 179 : 886 93.
11. Ross R, Ross XL, Schwing J, Längin T, Reske-Kunz AB. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J Immunol 1998 160 : 3776 82.
12. Ross R, Jonuleit H, Bros M et al. Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000 115 : 658 63.
13. Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E, Langhoff E. Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol 1996 148 : 593 600.
14. Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, Birkenbach M. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J Virol 1994 68 : 7320 8.
15. Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 1997 150 : 543 62.
16. Bros M, Ross XL, Pautz A, Reske-Kunz AB, Ross R. The human fascin gene promoter is highly active in mature dendritic cells due to a stage-specific enhancer. J Immunol 2003 171 : 1825 34.
17. Ross R, Sudowe S, Beisner J et al. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther 2003 10 : 1035 40.
18. Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Mol Ther 2003 8 : 567 75.
19. Timares L, Safer KM, Qu B, Takashima A, Johnston SA. Drug-inducible, dendritic cell-based genetic immunization. J Immunol 2003 170 : 5483 90.
20. + T cell responses in gene gun DNA immunization. J Immunol 2001 167 : 5549 57.
21. Hon H, Oran A, Brocker T, Jacob J. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J Immunol 2005 174 : 5233 42.
22. Lauterbach H, Gruber A, Ried C, Cheminay C, Brocker T. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J Immunol 2006 176 : 4600 7.
23. Casatorres J, Navarro JM, Blessing M, Jorcano JL. Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. Fundamental role of an AP-1 element. J Biol Chem 1994 269 : 20489 96.
24. Sudowe S, Montermann E, Steitz J, Tüting T, Knop J, Reske-Kunz AB. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther 2002 9 : 147 56.
25. Ludwig-Portugall I, Montermann E, Kremer A, Reske-Kunz AB, Sudowe S. Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination. J Allergy Clin Immunol 2004 114 : 951 7.
26. Sudowe S, Arps V, Vogel T, Kölsch E. The role of interleukin-4 in the regulation of sequential isotype switch from immunoglobulin G1 to immunoglobulin E antibody production. Scand J Immunol 2000 51 : 461 71.
27. Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J Allergy Clin Immunol 2006 117 : 196 203.
28. Jiang CK, Epstein HS, Tomic M, Freedberg IM, Blumenberg M. Functional comparison of the upstream regulatory DNA sequences of four human epidermal keratin genes. J Invest Dermatol 1991 96 : 162 7.
29. Weiss R, Scheiblhofer S, Gabler M, Ferreira F, Leitner WW, Thalhamer J. Is genetic vaccination against allergy possible? Int Arch Allergy Immunol 2006 139 : 332 45.
30. Scheiblhofer S, Stoecklinger A, Gruber C, Hauser-Kronberger C, Alinger B, Hammerl P, Thalhamer J, Weiss R. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Mol Immunol 2007 44 : 1879 87.
31. Hsu CH, Chua KY, Tao MH, Huang SK, Hsieh KH. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int Immunol 1996 8 : 1405 11.
32. Lee DJ, Tighe H, Corr M, Roman M, Carson DA, Spiegelberg HL, Raz E. Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells. Int Arch Allergy Immunol 1997 113 : 227 30.
33. Maecker HT, Hansen G, Walter DM, DeKruyff RH, Levy S, Umetsu DT. Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 2001 166 : 959 65.
34. Peng HJ, Su SN, Chang ZN, Chao PL, Kuo SW, Tsai LC. Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11. Vaccine 2002 20 : 1761 8.
35. Adel-Patient K, Creminon C, Boquet D, Wal JM, Chatel JM. Genetic immunization with bovine β-lactoglobulin cDNA induces a preventive and persistent inhibition of specific anti-BLG IgE response in mice. Int Arch Allergy Immunol 2001 126 : 59 67.
36. + T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response. Eur J Immunol 2002 32 : 1631 9.
37. Hochreiter R, Stepanoska T, Ferreira F, Valenta R, Vrtala S, Thalhamer J, Hartl A. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen deivatives of Bet v 1, the major birch-pollen allergen. Eur J Immunol 2003 33 : 1667 76.
38. Gabler M, Scheiblhofer S, Kern K et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 2006 118 : 734 41.
39. + T cells. Annu Rev Immunol 1994 12 : 635 73.
40. Snapper CM, Paul WE. Interferon-β and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987 236 : 944 7.
41. Missero C, Serra C, Stenn K, Dotto GP. Skin-specific expression of a truncated Ela oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation. J Cell Biol 1993 121 : 1109 20.
42. Ramirez A, Bravo A, Jorcano JL, Vidal M. Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994 58 : 53 64.
43. Amendt C, Schirmacher P, Weber H, Blessing M. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an accelaeration of carcinoma development. Oncogene 1998 17 : 25 34.
44. Paulson QX, McArthur MJ, Johnson DG. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 2006 5 : 184 90.
45. + thymic epithelial cells. J Immunol 2007 178 : 829 37.
46. Shelley CS, Arnaout MA. The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci USA 1991 88 : 10525 9.
47. Dziennis S, Van Etten RA, Pahl HL, Morris DL, Rothstein TL, Blosch CM, Perlmutter RM, Tenen DG. The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 1995 85 : 319 29.
48. Kouskoff V, Fehling HJ, Lemeur M, Benoist C, Mathis D. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J Immunol Methods 1993 166 : 287 91.
49. Groux H, Cottrez F, Rouleau M et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 1999 162 : 1723 9.
50. Becker D, Reske-Kunz AB, Knop J, Reske K. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langehans cells. Eur J Immunol 1991 21 : 1213 20.
51. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997 185 : 541 50.
52. Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, Lane P. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999 29 : 1610 6.
53. Ban E, Dupré L, Hermann E et al. CpG motifs induce Langerhans cell migration in vivo. Int Immunol 2000 12 : 737 45.
54. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001 166 : 5688 94.
55. Delgado M, Gonzalez-Rey E, Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 2005 175 : 7311 24.
56. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C, Carbone FR, Heath WR. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001 166 : 6099 103.
57. + T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J Immunol 2002 169 : 4951 60.
58. Kurts C, Miller JF, Subramaniam RM, Carbone FR, Heath WR. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998 188 : 409 14.
59. Klostermann B, Bellinghausen I, Böttcher I, Petersen A, Becker WM, Knop J, Saloga J. Modification of the human allergic immune response by allergen-DNA-transfected dendritic cells in vitro. J Allergy Clin Immunol 2004 113 : 327 33.
60. Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 1997 61 : 125 32.
61. Timares L, Takashima A, Johnston SA. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc Natl Acad Sci USA 1998 95 : 13147 52.
62. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995 81 : 979 82.